Vollebregt E - Search Results

1

Large language model AI chatbots require approval as medical devices.

Gilbert S, Harvey H, Melvin T, Vollebregt E, Wicks P. Gilbert S, et al. Among authors: vollebregt e. Nat Med. 2023 Oct;29(10):2396-2398. doi: 10.1038/s41591-023-02412-6. Nat Med. 2023. PMID: 37391665 No abstract available.

2

Can Apple and Google continue as health app gatekeepers as well as distributors and developers?

Sadare O, Melvin T, Harvey H, Vollebregt E, Gilbert S. Sadare O, et al. Among authors: vollebregt e. NPJ Digit Med. 2023 Jan 31;6(1):8. doi: 10.1038/s41746-023-00754-6. NPJ Digit Med. 2023. PMID: 36721023 Free PMC article. Review.

3

Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine.

Orth M, Vollebregt E, Trenti T, Shih P, Tollanes M, Sandberg S. Orth M, et al. Among authors: vollebregt e. Clin Chem Lab Med. 2022 Dec 26;61(4):696-702. doi: 10.1515/cclm-2022-1227. Print 2023 Mar 28. Clin Chem Lab Med. 2022. PMID: 36565304 Free article.

4

Regulation of Molecular Diagnostics.

Javitt GH, Vollebregt ER. Javitt GH, et al. Among authors: vollebregt er. Annu Rev Genomics Hum Genet. 2022 Aug 31;23:653-673. doi: 10.1146/annurev-genom-121521-010416. Annu Rev Genomics Hum Genet. 2022. PMID: 36044907 Free article. Review.

5

Hypomorphic NOTCH3 alleles do not cause CADASIL in humans.

Rutten JW, Boon EM, Liem MK, Dauwerse JG, Pont MJ, Vollebregt E, Maat-Kievit AJ, Ginjaar HB, Lakeman P, van Duinen SG, Terwindt GM, Lesnik Oberstein SA. Rutten JW, et al. Among authors: vollebregt e. Hum Mutat. 2013 Nov;34(11):1486-9. doi: 10.1002/humu.22432. Epub 2013 Oct 7. Hum Mutat. 2013. PMID: 24000151

6

Can regenerative medicine save Big Pharma’s business model from the patent cliff?

Denoon A, Vollebregt E. Denoon A, et al. Among authors: vollebregt e. Regen Med. 2010 Sep;5(5):687-90. doi: 10.2217/rme.10.68. Regen Med. 2010. PMID: 20868323 No abstract available.

7

Extraterritorial reach of the FCPA: recommendations for U.S. medical device companies with activities in Europe.

Vollebregt E. Vollebregt E. Food Drug Law J. 2010;65(2):347-65, iii. Food Drug Law J. 2010. PMID: 24475545

8

Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization.

White S, Kalf M, Liu Q, Villerius M, Engelsma D, Kriek M, Vollebregt E, Bakker B, van Ommen GJ, Breuning MH, den Dunnen JT. White S, et al. Among authors: vollebregt e. Am J Hum Genet. 2002 Aug;71(2):365-74. doi: 10.1086/341942. Epub 2002 Jul 8. Am J Hum Genet. 2002. PMID: 12111668 Free PMC article.

9

Cerebral microbleeds in CADASIL.

Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, Ferrari MD, Breuning MH, Haan J; Dutch CADASIL Research Group. Lesnik Oberstein SA, et al. Among authors: vollebregt e. Neurology. 2001 Sep 25;57(6):1066-70. doi: 10.1212/wnl.57.6.1066. Neurology. 2001. PMID: 11571335

10

Mammary gland-specific hypomethylation of Hpa II sites flanking the bovine alpha S1-casein gene.

Platenburg GJ, Vollebregt EJ, Karatzas CN, Kootwijk EP, De Boer HA, Strijker R. Platenburg GJ, et al. Among authors: vollebregt ej. Transgenic Res. 1996 Nov;5(6):421-31. doi: 10.1007/BF01980207. Transgenic Res. 1996. PMID: 8840525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters